Table 12 |
|||
|
Comparison of best classification accuracy for the Prostate Cancer dataset |
|||
|
Methods (feature selection + classification) |
#Selected genes |
#Correctly classified samples (accuracy) |
Rule-based classifier |
|
|
|||
|
depended degree + decision rules [this work] |
1 |
31 (91.18%) |
yes |
|
|
|||
|
2 |
27 (79.41%) |
||
|
|
|||
|
TSP [14] |
2 |
32 (94.12%) |
yes |
|
|
|||
|
PCLs [50] |
unknown |
33 (97.06%) |
yes |
|
|
|||
|
discretization + Single C4.5 [11] |
unknown |
23 (67.65%) |
yes |
|
|
|||
|
discretization + Bagging C4.5 [11] |
unknown |
25 (73.53%) |
yes |
|
|
|||
|
discretization + AdaBoost C4.5 [11] |
unknown |
23 (67.65%) |
yes |
|
|
|||
|
RCBT [13] |
unknown |
33 (97.06%) |
yes |
|
|
|||
|
SVMs [13] |
unknown |
27 (79.41%) |
no |
|
|
|||
|
signal to noise ratios + k-NNs [18]d |
4 |
26 (77.2%) |
no |
|
|
|||
|
16 |
29 (85.7%) |
no |
|
|
|
|||
|
dIn [18], as both raw and normalized datasets were used, two groups of prediction results were obtained. Here, we chose their results from the normalized dataset. Another small difference is that we obtained the dataset from the Kent Ridge Bio-medical Data Set Repository, where the prostate test set includes 25 tumor and 9 normal samples instead of the 27 tumor and 8 normal samples studied in [69]. To facilitate comparison, the correctly classified sample numbers were calculated according to the total of 34 samples. |
|||
|
Wang and Gotoh BMC Medical Genomics 2009 2:64 doi:10.1186/1755-8794-2-64 |
|||